Comparison of treatments for preventing lower urinary tract symptoms after BCG immunotherapy of bladder tumors : a systematic review and network meta-analysis

Abstract Background Bacillus Calmette-Guerin (BCG) immunotherapy is the standard adjuvant treatment for high-risk, non-muscle invasive bladder cancer (NMIBC). However, BCG immunotherapy is commonly accompanied by significant lower urinary tract symptoms (LUTS) including symptoms such as urinary urge...

詳細記述

書誌詳細

出版年:	BMC Urology
主要な著者:	Zihao Chen, Xin Chen, Dingchao Li, Jingang jian, Chang Yao, Xuedong Wei, Jianquan Hou
フォーマット:	論文
言語:	英語
出版事項:	BMC 2025-01-01
主題:	BCG Network meta-analysis LUTS Bladder cancer Immunotherapy
オンライン･アクセス:	https://doi.org/10.1186/s12894-024-01675-6